Microbe-microbe interactions during Clostridioides difficile infection

被引:35
作者
Abbas, Arwa [1 ]
Zackular, Joseph P. [1 ,2 ]
机构
[1] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Protect Immun, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
GUT MICROBIOTA; INTESTINAL MICROBIOTA; ANTIBIOTIC-TREATMENT; SPORE GERMINATION; BILE; ACID; EPIDEMIOLOGY; METABOLISM; BACTERIA; GROWTH;
D O I
10.1016/j.mib.2020.01.016
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Clostridioides difficile is the leading cause of hospital-acquired gastrointestinal infections and a major public health burden in the United States. C. difficile infection causes a spectrum of disease from mild diarrhea to severe complications such as pseudomembranous colitis, toxic megacolon and death. This broad range of disease is only partially explained by bacterial genetic factors, host genetics, comorbidities and previous drug exposures. Another important factor is the gut microbiome, the disruption of which results in a loss of colonization resistance to C. difficile. Here, we review how gut microbiota and their metabolites impact C. difficile virulence and influence disease.
引用
收藏
页码:19 / 25
页数:7
相关论文
共 63 条
[1]   Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles [J].
Allegretti, J. R. ;
Kearney, S. ;
Li, N. ;
Bogart, E. ;
Bullock, K. ;
Gerber, G. K. ;
Bry, L. ;
Clish, C. B. ;
Alm, E. ;
Korzenik, J. R. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (11) :1142-1153
[2]   RETRACTED: Clostridium scindens Is Present in the Gut Microbiota during Clostridium difficile Infection: a Metagenomic and Culturomic Analysis (Retracted Article) [J].
Amrane, Sophie ;
Bachar, Dipankar ;
Lagier, Jean Christophe ;
Raoult, Didier .
JOURNAL OF CLINICAL MICROBIOLOGY, 2018, 56 (05)
[3]   An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection [J].
Antharam, Vijay C. ;
McEwen, Daniel C. ;
Garrett, Timothy J. ;
Dossey, Aaron T. ;
Li, Eric C. ;
Kozlov, Andrew N. ;
Mesbah, Zhubene ;
Wang, Gary P. .
PLOS ONE, 2016, 11 (02)
[4]   Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea [J].
Antharam, Vijay C. ;
Li, Eric C. ;
Ishmael, Arif ;
Sharma, Anuj ;
Mai, Volker ;
Rand, Kenneth H. ;
Wang, Gary P. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (09) :2884-2892
[5]   Global burden of Clostridium difficile infections: a systematic review and meta-analysis [J].
Balsells, Evelyn ;
Shi, Ting ;
Leese, Callum ;
Lyell, Iona ;
Burrows, John ;
Wiuff, Camilla ;
Campbell, Harry ;
Kyaw, Moe H. ;
Nair, Harish .
JOURNAL OF GLOBAL HEALTH, 2019, 9 (01)
[6]   Lactobacillus delbrueckii ssp bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells [J].
Banerjee, Pratik ;
Merkel, Glenn J. ;
Bhunia, Arun K. .
GUT PATHOGENS, 2009, 1
[7]   Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile [J].
Buffie, Charlie G. ;
Bucci, Vanni ;
Stein, Richard R. ;
McKenney, Peter T. ;
Ling, Lilan ;
Gobourne, Asia ;
No, Daniel ;
Liu, Hui ;
Kinnebrew, Melissa ;
Viale, Agnes ;
Littmann, Eric ;
van den Brink, Marcel R. M. ;
Jenq, Robert R. ;
Taur, Ying ;
Sander, Chris ;
Cross, Justin R. ;
Toussaint, Nora C. ;
Xavier, Joao B. ;
Pamer, Eric G. .
NATURE, 2015, 517 (7533) :205-U207
[8]   Profound Alterations of Intestinal Microbiota following a Single Dose of Clindamycin Results in Sustained Susceptibility to Clostridium difficile-Induced Colitis [J].
Buffie, Charlie G. ;
Jarchum, Irene ;
Equinda, Michele ;
Lipuma, Lauren ;
Gobourne, Asia ;
Viale, Agnes ;
Ubeda, Carles ;
Xavier, Joao ;
Pamer, Eric G. .
INFECTION AND IMMUNITY, 2012, 80 (01) :62-73
[9]  
CDC, 2018, CLOSTR DIFF, V2019
[10]   The role of toxins in Clostridium difficile infection [J].
Chandrasekaran, Ramyavardhanee ;
Lacy, D. Borden .
FEMS MICROBIOLOGY REVIEWS, 2017, 41 (06) :723-750